Serum brain injury biomarkers are gestationally and post-natally regulated in non-brain injured neonates

[1]  A. Everett,et al.  Tiny Bodies, Big Needs: Prospective Biobanking of Neonatal Clinical Remnant Samples. , 2021, Biopreservation and biobanking.

[2]  F. Northington,et al.  Blood Biomarkers for Neonatal Hypoxic-Ischemic Encephalopathy in the Presence and Absence of Sentinel Events , 2020, Journal of Perinatology.

[3]  F. Northington,et al.  Plasma and CSF Candidate Biomarkers of Neonatal Encephalopathy Severity and Neurodevelopmental Outcomes. , 2020, The Journal of pediatrics.

[4]  M. Escobar,et al.  BDNF induces in vivo long-lasting enhancement of synaptic transmission and structural reorganization at the hippocampal mossy fibers in a transcription and translation-independent manner , 2019, Neurobiology of Learning and Memory.

[5]  Celaleddin Soyalp,et al.  NRGN, S100B and GFAP levels are significantly increased in patients with structural lesions resulting from mild traumatic brain injuries , 2019, Clinical Neurology and Neurosurgery.

[6]  T. Huisman,et al.  Ultrasound Predicts White Matter Integrity after Hypothermia Therapy in Neonatal Hypoxic‐Ischemic Injury , 2019, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[7]  M. Johnston,et al.  Preschool Language Outcomes following Perinatal Hypoxic-Ischemic Encephalopathy in the Age of Therapeutic Hypothermia , 2019, Developmental Neuroscience.

[8]  M. Johnston,et al.  Correlation Between White Matter Injury Identified by Neonatal Diffusion Tensor Imaging and Neurodevelopmental Outcomes Following Term Neonatal Asphyxia and Therapeutic Hypothermia: An Exploratory Pilot Study , 2019, Journal of child neurology.

[9]  W. Mahle,et al.  Association of intraoperative circulating‐brain injury biomarker and neurodevelopmental outcomes at 1 year among neonates who have undergone cardiac surgery , 2019, The Journal of thoracic and cardiovascular surgery.

[10]  K. Blennow,et al.  Expression and secretion of synaptic proteins during stem cell differentiation to cortical neurons , 2018, Neurochemistry International.

[11]  F. Northington,et al.  Blood biomarkers for evaluation of perinatal encephalopathy: state of the art , 2018, Current opinion in pediatrics.

[12]  E. Graham,et al.  Risk Factors for Neonatal Hypoxic-Ischemic Encephalopathy in the Absence of Sentinel Events , 2018, American Journal of Perinatology.

[13]  R. McKinstry,et al.  Plasma Biomarkers of Brain Injury in Neonatal Hypoxic‐Ischemic Encephalopathy , 2018, The Journal of pediatrics.

[14]  E. Heitmiller,et al.  Impaired cerebral autoregulation and elevation in plasma glial fibrillary acidic protein level during cardiopulmonary bypass surgery for CHD , 2017, Cardiology in the Young.

[15]  K. Blennow A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood , 2017, Neurology and Therapy.

[16]  B. Poindexter,et al.  Effect of Depth and Duration of Cooling on Death or Disability at Age 18 Months Among Neonates With Hypoxic-Ischemic Encephalopathy: A Randomized Clinical Trial , 2017, JAMA.

[17]  V. Pierrat,et al.  Leading causes of preterm delivery as risk factors for intraventricular hemorrhage in very preterm infants: results of the EPIPAGE 2 cohort study , 2017, American journal of obstetrics and gynecology.

[18]  B. Torres-Mendoza,et al.  Proinflammatory Cytokines, Enolase and S-100 as Early Biochemical Indicators of Hypoxic-Ischemic Encephalopathy Following Perinatal Asphyxia in Newborns. , 2017, Pediatrics and neonatology.

[19]  E. Molloy,et al.  Perinatal Asphyxia and Erythropoietin and VEGF: Serial Serum and Cerebrospinal Fluid Responses , 2016, Neonatology.

[20]  H. Lv,et al.  Neonatal hypoxic ischemic encephalopathy-related biomarkers in serum and cerebrospinal fluid. , 2015, Clinica chimica acta; international journal of clinical chemistry.

[21]  Khatuna Makharoblidze,et al.  The effects of selective head cooling versus whole-body cooling on some neural and inflammatory biomarkers: a randomized controlled pilot study , 2015, Italian Journal of Pediatrics.

[22]  Frederick K Korley,et al.  Serum neurogranin measurement as a biomarker of acute traumatic brain injury. , 2015, Clinical biochemistry.

[23]  Wei Ma,et al.  Expression pattern of NeuN and GFAP during human fetal spinal cord development , 2015, Child's Nervous System.

[24]  R. Romero,et al.  Clinical chorioamnionitis at term V: umbilical cord plasma cytokine profile in the context of a systemic maternal inflammatory response , 2015, Journal of perinatal medicine.

[25]  Yvonne W Wu,et al.  Neonatal Encephalopathy and Neurologic Outcome, Second Edition , 2014, Pediatrics.

[26]  H. Makizako,et al.  A Large, Cross-Sectional Observational Study of Serum BDNF, Cognitive Function, and Mild Cognitive Impairment in the Elderly , 2014, Front. Aging Neurosci..

[27]  B. Adams-Huet,et al.  Biomarkers for severity of neonatal hypoxic-ischemic encephalopathy and outcomes in newborns receiving hypothermia therapy. , 2014, The Journal of pediatrics.

[28]  Elke Edelmann,et al.  Pre- and postsynaptic twists in BDNF secretion and action in synaptic plasticity , 2014, Neuropharmacology.

[29]  C. Bramham,et al.  BDNF mechanisms in late LTP formation: A synthesis and breakdown , 2014, Neuropharmacology.

[30]  C. Duarte,et al.  BDNF-induced local protein synthesis and synaptic plasticity , 2014, Neuropharmacology.

[31]  K. Lui,et al.  Intraventricular Hemorrhage and Neurodevelopmental Outcomes in Extreme Preterm Infants , 2014, Pediatrics.

[32]  J. Jennings,et al.  Glial fibrillary acidic protein as a biomarker for periventricular white matter injury. , 2013, American journal of obstetrics and gynecology.

[33]  M. Johnston,et al.  Serum Biomarkers of MRI Brain Injury in Neonatal Hypoxic Ischemic Encephalopathy Treated With Whole-Body Hypothermia: A Pilot Study , 2013, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[34]  Mu-ming Poo,et al.  Neurotrophin regulation of neural circuit development and function , 2012, Nature Reviews Neuroscience.

[35]  P. Ancel 107 Survival of Very Preterm Children Born in 2011: First Results of the Epipage 2 Cohort Study , 2012, Archives of Disease in Childhood.

[36]  J. Jennings,et al.  Glial fibrillary acidic protein as a biomarker for neonatal hypoxic-ischemic encephalopathy treated with whole-body cooling. , 2011, American journal of obstetrics and gynecology.

[37]  G. Knudsen,et al.  Blood BDNF concentrations reflect brain-tissue BDNF levels across species. , 2011, The international journal of neuropsychopharmacology.

[38]  Nadia Badawi,et al.  Epidemiology of neonatal encephalopathy and hypoxic-ischaemic encephalopathy. , 2010, Early human development.

[39]  S. Shankaran,et al.  Perinatal Systemic Inflammatory Response Syndrome and Retinopathy of Prematurity , 2010, Pediatric Research.

[40]  Andrew Whitelaw,et al.  Neurological outcomes at 18 months of age after moderate hypothermia for perinatal hypoxic ischaemic encephalopathy: synthesis and meta-analysis of trial data , 2010, BMJ : British Medical Journal.

[41]  A. Sartorius,et al.  Correlations and Discrepancies between Serum and Brain Tissue Levels of Neurotrophins after Electroconvulsive Treatment in Rats , 2009, Pharmacopsychiatry.

[42]  Ben Vandermeer,et al.  Systematic review of biomarkers of brain injury in term neonatal encephalopathy. , 2009, Pediatric neurology.

[43]  J. Volpe Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances , 2009, The Lancet Neurology.

[44]  J. Bernal,et al.  RC3/neurogranin is expressed in pyramidal neurons of motor and somatosensory cortex in normal and denervated monkeys , 2005, The Journal of comparative neurology.

[45]  William Oh,et al.  Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. , 2005, The New England journal of medicine.

[46]  A. Raabe,et al.  GFAP versus S100B in serum after traumatic brain injury: relationship to brain damage and outcome. , 2004, Journal of neurotrauma.

[47]  W. Carlo,et al.  Umbilical cord plasma interleukin-6 concentrations in preterm infants and risk of neonatal morbidity. , 2004, American journal of obstetrics and gynecology.

[48]  E. Shooter,et al.  BDNF overexpression produces a long‐term increase in myelin formation in the peripheral nervous system , 2004, Journal of neuroscience research.

[49]  M. Schwald,et al.  Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets , 2002, Neuroscience Letters.

[50]  M. Blennow,et al.  Brain‐specific proteins in the cerebrospinal fluid of severely asphyxiated newborn infants , 2001, Acta paediatrica.

[51]  C. Baird,et al.  The pilot study. , 2000, Orthopedic nursing.

[52]  S. Grad,et al.  Strongly Enhanced Serum Levels of Vascular Endothelial Growth Factor (VEGF) after Poly-trauma and Burn , 1998, Clinical chemistry and laboratory medicine.

[53]  T Bonhoeffer,et al.  Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[54]  M. Blennow,et al.  Glial Fibrillary Acidic Protein in the Cerebrospinal Fluid: A Possible Indicator of Prognosis in Full-Term Asphyxiated Newborn Infants? , 1995, Pediatric Research.

[55]  Y. Ben-Ari,et al.  Neurogranin: immunocytochemical localization of a brain-specific protein kinase C substrate , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[56]  N. Paneth,et al.  White matter damage in preterm newborns--an epidemiologic perspective. , 1990, Early human development.

[57]  G. Fenichel Hypoxic-ischemic encephalopathy in the newborn. , 1983, Archives of neurology.

[58]  H. Thoenen,et al.  Purification of a new neurotrophic factor from mammalian brain. , 1982, The EMBO journal.

[59]  H. Sarnat,et al.  Neonatal encephalopathy following fetal distress. A clinical and electroencephalographic study. , 1976, Archives of neurology.

[60]  M. Wiesmann,et al.  Measurement of glial fibrillary acidic protein in human blood: analytical method and preliminary clinical results. , 1999, Clinical chemistry.

[61]  Markus Voelter,et al.  State of the Art , 1997, Pediatric Research.